Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Protein and Early Exercise in ICU Patients
NCT05877989Phase 4Completed
- Sponsor
- Tanta University
- Start
- Jul 2021
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in muscle weakness and critical illness (2 arms), sponsored by Tanta University. Primary endpoint: Quantitative changes (cross-section diameter) of rectus femoris muscle at 30 days. Started Jul 2021; status: completed.
02
Conditions
muscle weaknesscritical illness
Beyond the preview
Go deeper on NCT05877989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05877989.